Biotech · Private company · Deep River, CT, US
Thetis Pharmaceuticals LLC
Track this companyFree. Adds Thetis Pharmaceuticals LLC to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Metformin EicosapentaenoatePhase 1 · Diabetes Mellitus, Non-Insulin-DependentClinicalTrials.gov · fetched Nov 12, 2026
- Metformin HCl and VascepaPhase 1 · Diabetes Mellitus, Non-Insulin-DependentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPAPHASE1 · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02113163 · fetched Nov 12, 2026
NIH awards5
- Development of TP-317 for Ulcerative ColitisFiscal year 2026 · $669.9KNIH RePORTER 1SB1DK145287-01A1 · fetched Nov 12, 2026
- Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic CancerFiscal year 2026 · $271.4KNIH RePORTER 5R44CA278026-03 · fetched Nov 12, 2026
- Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic CancerFiscal year 2025 · $1.7MNIH RePORTER 4R44CA278026-02 · fetched Nov 12, 2026
- Development of TP-317 in Ulcerative ColitisFiscal year 2025 · $999.7KNIH RePORTER 5R44DK116460-06 · fetched Nov 12, 2026
- Development of TP-317 in Ulcerative ColitisFiscal year 2024 · $999.6KNIH RePORTER 5R44DK116460-05 · fetched Nov 12, 2026